Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.23 USD | -1.82% |
|
-10.28% | +90.00% |
Jun. 12 | Connect Biopharma Names New Chief Executive, Chair | MT |
May. 29 | Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+90.00% | 496M | |
+34.14% | 51.51B | |
-6.54% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+12.62% | 26.13B | |
-13.43% | 19.91B | |
+43.73% | 13.71B | |
+31.81% | 12.38B | |
-4.54% | 11.74B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Heron Therapeutics, Inc. Provides Sales Guidance for the Full Year 2021